Gwajin gaggawa na SARS-CoV-2 IgG/IgM
-
Gwajin gaggawa na SARS-CoV-2 IgM/IgG Antibody
REF Farashin 502090 Ƙayyadaddun bayanai Gwaje-gwaje 20 / Akwati Ka'idar ganowa Immunochromatographic bincike samfurori Dukan Jini / Magani / Plasma Amfani da Niyya Wannan shine saurin gwajin immuno-chromatographic don gano lokaci guda na IgM da IgG ƙwayoyin rigakafi zuwa kwayar cutar SARS-CoV-2 a cikin jinin ɗan adam, jini ko plasma. Gwajin yana iyakance a cikin Amurka don rarrabawa zuwa dakunan gwaje-gwaje da CLIA ta tabbatar don yin babban gwaji mai rikitarwa.
FDA ba ta sake duba wannan gwajin ba.
Sakamako mara kyau baya hana kamuwa da cutar SARS-CoV-2 mai tsanani.
Sakamakon gwajin rigakafin mutum bai kamata a yi amfani da shi ba don tantancewa ko keɓe kamuwa da cutar SARS-CoV-2 mai tsanani.
Kyakkyawan sakamako na iya kasancewa saboda kamuwa da cuta na baya ko na yanzu tare da nau'ikan coronavirus marasa SARS-CoV-2, kamar coronavirus HKU1, NL63, OC43, ko 229E.
